Atta Behfar, MD, PhD, co-founder and CEO of Rion, is Director of Cardiac Regeneration at Mayo Clinic, and specializes in heart transplant and invasive cardiac procedures. Dr. Behfar is a serial entrepreneur and innovator in the regenerative medicine field. His work has led to the development of a several regenerative technologies including cardiopoietic stem cells, which completed Phase II/III trials in Europe, and was approved by the FDA for phase III pivotal testing. Dr. Behfar's recent emphasis has been the design of novel biomatrices, exosome and RNA platforms to augment the retention of regenerative biologics in order to facilitate cell-free endogenous repair. These new technologies serve as the basis for Rion with an eye towards developing technological platforms that fundamentally change the approach to regenerative medicine, by delivering low cost and off-the-shelf therapies in a broad array of medical applications.